Cargando…

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886035/
https://www.ncbi.nlm.nih.gov/pubmed/33440069
http://dx.doi.org/10.1002/acn3.51295
_version_ 1783651711757320192
collection PubMed
description
format Online
Article
Text
id pubmed-7886035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78860352021-02-26 Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease Ann Clin Transl Neurol Corrigendum John Wiley and Sons Inc. 2021-01-13 /pmc/articles/PMC7886035/ /pubmed/33440069 http://dx.doi.org/10.1002/acn3.51295 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Corrigendum
Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title_full Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title_fullStr Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title_full_unstemmed Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title_short Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
title_sort corrigendum: comparing progression biomarkers in clinical trials of early alzheimer’s disease
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886035/
https://www.ncbi.nlm.nih.gov/pubmed/33440069
http://dx.doi.org/10.1002/acn3.51295